Omniab Inc Stock Today
OmniAb is selling for under 0.4 as of the 31st of January 2025; that is 5.26% up since the beginning of the trading day. The stock's lowest day price was 0.4. The performance scores are derived for the period starting the 1st of January 2025 and ending today, the 31st of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 30th of September 2021 | Category Healthcare | Classification Health Care |
Valuation Profit Patterns
Check how we calculate scores
OmniAb Stock Highlights
| CEO President | Matthew Foehr | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OmniAb can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand OmniAb's financial leverage. It provides some insight into what part of OmniAb's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OmniAb Inc (OABIW) is traded on NASDAQ Exchange in USA. It is located in 5980 Horton Street, EmeryVille, CA, United States, 94608 and employs 106 people. OmniAb is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry.
OmniAb generates positive cash flow from operations, but has no cash available
Check OmniAb Probability Of Bankruptcy
OmniAb Historical Income Statement
OmniAb Stock Against Markets
OmniAb Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OmniAb stock to make a market-neutral strategy. Peer analysis of OmniAb could also be used in its relative valuation, which is a method of valuing OmniAb by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
OmniAb Corporate Management
| Cia McCaffrey | Vice Talent | Profile | |
| Donna CPA | Senior Controller | Profile | |
| Bill Harriman | Senior Discovery | Profile | |
| Douglas Krafte | Senior Head | Profile | |
| MarieCecile DVM | Senior Genetics | Profile | |
| Charles JD | Chief Secretary | Profile |
Additional Tools for OmniAb Stock Analysis
When running OmniAb's price analysis, check to measure OmniAb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OmniAb is operating at the current time. Most of OmniAb's value examination focuses on studying past and present price action to predict the probability of OmniAb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OmniAb's price. Additionally, you may evaluate how the addition of OmniAb to your portfolios can decrease your overall portfolio volatility.